Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid

Table 1

Genes selected for qPCR analysis.

No	Gene	Name	Signaling pathway	Reported in TB	Reference
1	CCL-4	C-C motif chemokine ligand 4	Cytokine signaling in immune system, Toll-like receptor signaling pathway	Yes	[25]
2	CXCL-10	C-X-C motif chemokine ligand 10	Peptide ligand-binding receptors, Toll-like receptor signaling pathway, type II interferon signaling (IFNG)	Yes	[26, 27]
3	CXCL-11	C-X-C motif chemokine ligand 11	Peptide ligand-binding receptors, Toll-like receptor signaling pathway, type II interferon signaling (IFNG)	Yes	[24]
4	IFI44	Interferon-induced protein 44	Immune response IFN alpha/beta signaling pathway	Yes	[19]
5	IFI44L	Interferon-induced protein like 44	Immune response IFN alpha/beta signaling pathway	Yes	[19, 20]
6	IFIT1	Interferon-induced with tetraticopeptide repeats 1	Immune response IFN alpha/beta signaling pathway	Yes	[23]
7	IFNA	Interferon alpha 10	Immune response IFN alpha/beta signaling pathway	Yes	[19]
8	IL2RA	Interleukin 2 receptor subunit alpha	TGF-beta pathway, Th17 cell differentiation	Yes	[22]
9	RSAD2	Radical S-adenosyl methionine domain-containing 2	Immune response IFN alpha/beta signaling pathway	Yes	[23]
10	USP18	Ubiquitin-specific peptidase 18	Immune response IFN alpha/beta signaling pathway, antiviral mechanism by IFN-stimulated genes	Yes	[21]